LOBO LOBO TECHNOLOGIES LTD.
Executive Summary
LOBO TECHNOLOGIES LTD. is conducting a best efforts public offering of 3,921,567 Units at $0.51 per Unit, raising approximately $2 million in gross proceeds. Each Unit consists of one Class A Ordinary Share, one Series A Warrant, and one Series B Warrant. The Series B Warrants contain a 'zero cash exercise price option' allowing holders to receive up to five shares per warrant without additional payment, meaning the company will likely receive no additional funds from their exercise. The offering is priced at a 1.9% discount to the last reported sale price of $0.5199 and results in significant dilution for existing shareholders.
Actionable Insight
Traders should be aware of the significant dilution from this offering and the potential for massive future dilution from the Series B Warrants. The company's history of losses and the fact that it will receive no additional funds from the exercise of the most valuable warrants suggest weak fundamentals. Monitor the stock for increased selling pressure post-offering.
Key Facts
- LOBO is offering 3,921,567 Units at $0.51 per Unit, raising $2 million in gross proceeds.
- Each Unit includes one Class A Ordinary Share, one Series A Warrant, and one Series B Warrant.
- The Series B Warrants have a 'zero cash exercise price option' allowing holders to receive up to five shares per warrant without additional payment, meaning the company will likely receive no additional funds from their exercise.
- The offering is priced at a 1.9% discount to the last reported sale price of $0.5199 per share.
- The offering results in significant dilution, increasing the total number of Class A Ordinary Shares from 8.84 million to 12.76 million, a 44.4% increase.
- The company reported a net loss of $2.62 million for the six months ended June 30, 2025, and has a history of financial losses.
Financial Impact
The offering will raise approximately $1.85 million in net proceeds after expenses. The 'zero cash exercise price option' on the Series B Warrants could result in the issuance of up to 19.6 million additional shares without any additional proceeds to the company.
Risk Factors
- Significant immediate dilution to existing shareholders
- Massive potential future dilution from Series B Warrants
- Company has a history of financial losses
- No additional proceeds from the exercise of Series B Warrants
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B4 Filing (Primary) | 0001493152-26-012602 |
| Document: 0001493152-26-012602-index-headers.html | 0001493152-26-012602 |
| Document: 0001493152-26-012602-index.html | 0001493152-26-012602 |
| Document: 0001493152-26-012602.txt | 0001493152-26-012602 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
7d ago
|
Press Release
| $0.8810 $0.8510 | ▼ −3.41% | ▼ −2.71% | $0.7660 (−13.05%) |
|
May 26, 2026
14d ago
|
Press Release
| $0.7220 $0.7380 | ▲ +2.22% | ▲ +2.20% | $0.7660 (+6.09%) |
|
Apr 1, 2026
9w ago
|
6-K
| $0.4460 $0.4400 | ▼ −1.35% | ▼ −1.42% | $0.7660 (+71.75%) |
|
Mar 25, 2026
10w ago
|
424B4
| $0.4480 $0.4340 | ▲ +3.13% | ▲ +1.36% | $0.7660 (−70.98%) |
|
Mar 24, 2026
11w ago
|
EFFECT
| $0.4100 $0.4480 | ▲ +9.27% | ▲ +8.70% | $0.7660 (+86.83%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $0.4100 $0.4480 | ▲ +9.27% | ▲ +8.70% | $0.7660 (+86.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access